"ISIS" Study of Sex Differences in Characteristics of Adiposity and Metabolism

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

23 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-08-31

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to characterize differences in the structure and function of the body fat from two different parts of the body in young, healthy men and women. We will also compare how differences in metabolism relate to characteristics of body fat and its functions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Risk of Metabolic Adaptation After Weight Loss

NCT05139420

Weight Loss Obesity

ACTIVE_NOT_RECRUITING NA

The Belly Fat Study: Nutritional Intervention to Improve Metabolic Health in Subjects With Increased Abdominal Adiposity

NCT02194504

Abdominal Obesity Liver Fat

COMPLETED NA

Systemic and White Adipose Tissue Inflammatory Profile in Lean Versus Obese Individuals

NCT04078776

Inflammation Obesity Inflammatory Response +1 more

COMPLETED

How Menopause Affects Lipid Metabolism in the Visceral Fat Depots

NCT02524457

Insulin Sensitivity and Lipid Metabolism

UNKNOWN

Re-energize With Nutrition, Exercise and Weight Loss

NCT00712127

Obesity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Following screening, the study comprises of a total of 3 clinic visits (2 outpatient visits, and 1 overnight stay) completed during a 2 week period. For the outpatient visits, body composition (by DEXA), visceral fat (by CT), ectopic fat (by MRS and CT) and aerobic fitness (by VO2max test) will be measured. Women will also have ovarian parameters (follicle size and number) measured during the MR scans. Following an overnight stay in the inpatient unit, insulin sensitivity (by euglycemic hyperinsulinemic clamp), interstitial lipolysis (by microdialysis), whole body lipolysis and glycolysis (by stable isotopes), abdominal adipose tissue oxygen content (Hunt and Direct Methods) will be measured and a subcutaneous fat biopsy of the abdominal and gluteo-femoral tissue will be collected. Women will complete all testing in the follicular phase of the menstrual cycle.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diabetic men and women ages 40 to 60, inclusive and healthy men and women ages 20 to 35, inclusive.
* Body mass index (a ratio of height to weight) less than 25 kg/m2 (lean group) or 27 to 35 kg/m2 (overweight/obese group).
* Not involved in regular physical activity (more than 3 times per week).
* Women must have regular menstrual cycles (1 menstrual bleeding each month).

Exclusion Criteria

* For men in the overweight/obese group, you have a waist circumference less than 102cm (40 inches).
* You smoke.
* You have liver, kidney, thyroid or heart diseases, or cancer.
* You are claustrophobic.
* You have metal objects in your body such as implanted rods or surgical clips.
* If you are not diabetic and you are taking steroids, protease inhibitors, statins, antihypertensives or medications known to alter glucose or lipid metabolism.
* If you are diabetic and you are taking steroids, protease inhibitors, or injectable antihyperglycemic medications (oral diabetic meds are allowed.)
* If you are a woman, you are pregnant or breast feeding or trying to become pregnant (women who become pregnant throughout the study will be excluded).
* If you are a woman, you are using hormonal contraceptives or have anovulation, androgen excess or irregular menstrual cycles (less than 1 cycle per month).
* You have previously had a BMI \>35 kg/m2.
* You are not able to eat the foods provided by PBRC.
* If your weight has not been stable.

Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes